Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

FRA:NVJP - Deutsche Boerse Ag - BE0974320526 - Common Stock - Currency: EUR

8.905  -0.58 (-6.11%)

Fundamental Rating

3

Taking everything into account, NVJP scores 3 out of 10 in our fundamental rating. NVJP was compared to 61 industry peers in the Chemicals industry. Both the profitability and financial health of NVJP have multiple concerns. NVJP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NVJP had negative earnings in the past year.
In the past year NVJP had a positive cash flow from operations.
NVJP had positive earnings in 4 of the past 5 years.
In the past 5 years NVJP always reported a positive cash flow from operatings.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

NVJP has a worse Return On Assets (-29.62%) than 84.13% of its industry peers.
Looking at the Return On Equity, with a value of -80.63%, NVJP is doing worse than 82.54% of the companies in the same industry.
Industry RankSector Rank
ROA -29.62%
ROE -80.63%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

NVJP has a Gross Margin of 8.12%. This is in the lower half of the industry: NVJP underperforms 77.78% of its industry peers.
In the last couple of years the Gross Margin of NVJP has grown nicely.
The Profit Margin and Operating Margin are not available for NVJP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.07%
GM growth 5Y6.62%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

3

2. Health

2.1 Basic Checks

NVJP does not have a ROIC to compare to the WACC, probably because it is not profitable.
NVJP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 2.22 indicates that NVJP is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of NVJP (2.22) is comparable to the rest of the industry.
NVJP has a debt to FCF ratio of 9.59. This is a negative value and a sign of low solvency as NVJP would need 9.59 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.59, NVJP is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
NVJP has a Debt/Equity ratio of 0.55. This is a neutral value indicating NVJP is somewhat dependend on debt financing.
NVJP has a Debt to Equity ratio (0.55) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 9.59
Altman-Z 2.22
ROIC/WACCN/A
WACC7.03%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

NVJP has a Current Ratio of 1.62. This is a normal value and indicates that NVJP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.62, NVJP is in line with its industry, outperforming 42.86% of the companies in the same industry.
A Quick Ratio of 0.82 indicates that NVJP may have some problems paying its short term obligations.
NVJP's Quick ratio of 0.82 is on the low side compared to the rest of the industry. NVJP is outperformed by 76.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.82
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

3

3. Growth

3.1 Past

NVJP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -866.06%.
The Revenue has grown by 22.09% in the past year. This is a very strong growth!
The Revenue has been decreasing by -3.21% on average over the past years.
EPS 1Y (TTM)-866.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1013.41%
Revenue 1Y (TTM)22.09%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%721.1%

3.2 Future

Based on estimates for the next years, NVJP will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.02% on average per year.
NVJP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.48% yearly.
EPS Next Y-0.51%
EPS Next 2Y3.66%
EPS Next 3Y6.15%
EPS Next 5Y12.02%
Revenue Next Year28.74%
Revenue Next 2Y14.08%
Revenue Next 3Y11.83%
Revenue Next 5Y1.48%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

NVJP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
NVJP is valuated reasonably with a Price/Forward Earnings ratio of 8.63.
Based on the Price/Forward Earnings ratio, NVJP is valued cheaper than 95.24% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. NVJP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 8.63
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, NVJP is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.66
EV/EBITDA N/A
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.66%
EPS Next 3Y6.15%

6

5. Dividend

5.1 Amount

NVJP has a Yearly Dividend Yield of 3.70%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, NVJP pays a better dividend. On top of this NVJP pays more dividend than 80.95% of the companies listed in the same industry.
NVJP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 3.7%

5.2 History

The dividend of NVJP has a limited annual growth rate of 1.00%.
Dividend Growth(5Y)1%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

The earnings of NVJP are negative and hence is the payout ratio. NVJP will probably not be able to sustain this dividend level.
NVJP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-6.52%
EPS Next 2Y3.66%
EPS Next 3Y6.15%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

UMICORE

FRA:NVJP (3/7/2025, 7:00:00 PM)

8.905

-0.58 (-6.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)N/A N/A
Inst Owners46.99%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.19B
Analysts52.5
Price Target11.97 (34.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.7%
Yearly Dividend0.8
Dividend Growth(5Y)1%
DP-6.52%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.6%
PT rev (3m)-16.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.98%
EPS NY rev (3m)-6.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)27.12%
Revenue NY rev (3m)26.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.63
P/S 0.1
P/FCF 7.66
P/OCF 2.53
P/B 0.6
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-12.27
EYN/A
EPS(NY)1.03
Fwd EY11.59%
FCF(TTM)1.16
FCFY13.06%
OCF(TTM)3.53
OCFY39.59%
SpS90.5
BVpS14.86
TBVpS13.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.62%
ROE -80.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.12%
FCFM 1.28%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.07%
GM growth 5Y6.62%
F-Score4
Asset Turnover2.24
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 9.59
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 0.82
Altman-Z 2.22
F-Score4
WACC7.03%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.56%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-866.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1013.41%
EPS Next Y-0.51%
EPS Next 2Y3.66%
EPS Next 3Y6.15%
EPS Next 5Y12.02%
Revenue 1Y (TTM)22.09%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%721.1%
Revenue Next Year28.74%
Revenue Next 2Y14.08%
Revenue Next 3Y11.83%
Revenue Next 5Y1.48%
EBIT growth 1Y-545.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.97%
EBIT Next 3Y22.52%
EBIT Next 5Y14.08%
FCF growth 1Y81.43%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-16.68%
OCF growth 3Y-11.62%
OCF growth 5Y12.63%